News

Ethicon Announced Agreement to Acquire Neuwave Medical® Inc.

NeuWave Medical Technology Offers Minimally Invasive Intervention Option for Patients with Soft Tissue Lesions

CINCINNATI, OH.– March , 2016 – Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.

Read More...

NeuWave Medical® Inc., a privately held medical device company focused on developing disruptive technology for use in the ablation of soft-tissue lesions has completed its Series C financing, led by Versant Ventures. The financing round was oversubscribed with all existing investors participating, including H.I.G. BioVentures, Venture Investors and others. The capital raised will be used to expand commercialization efforts, and to develop the next generation of breakthrough innovations.

Read More...

- First and Only, Integrated In-Procedure Confirmation for Ablation of Soft Tissue Lesions -

MADISON, WI. / MINNEAPOLIS, MN., – JULY 30, 2015 - NeuWave Medical® Inc., a privately held medical device company focused on developing disruptive technology for use in the ablation of soft-tissue lesions has received FDA clearance for its new Ablation Confirmation™ (AC) software integrated into the NeuWave Intelligent Ablation System. The totality of the NeuWave System now with AC gives physicians the first, and only, in-procedure confirmation of ablation.

Ablation Confirmation™ (AC), is a Computed Tomography (CT) image processing software package that assists physicians in identifying ablation targets, assessing proper ablation probe placement and confirming ablation zones post-procedure. AC imports images from CT scanners and facility PACS systems for display and processing during ablation procedures and is accessible to physicians via a dedicated monitor with its own user interface on the NeuWave Intelligent Ablation System. The clearance of AC marks the first and only, integrated in-procedure ablation confirmation software available on an ablation system.

Read More...

NeuWave Medical® has received 510K marketing clearance from the US Food and Drug Administration (FDA) for the CertuSurgGT Surgical Tool. The device is designed to produce focal, rapid coagulation of soft tissue in open surgical applications, including planar coagulation performed prior to tissue resection.

NeuWave Medical® has received 510K marketing clearance from the United States Food and Drug Administration (FDA) for the CertuSurgGT Surgical Tool. The device is designed to produce focal, rapid coagulation of soft tissue in open surgical applications, including planar coagulation performed prior to tissue resection.

Link to the University of Wisconsin - Madison Department of Radiology to stay current on tumor ablation research.

Read More...

Upcoming Events

  • Select Category